News and features

Articles

Showing 1 - 10 of 20

News & Analysis

Han Kun provides data compliance counsel to Lucas GC's listing on Nasdaq

06 March 2024 by Han Kun Law Offices

Han Kun provides data compliance counsel to Lucas GC's listing on Nasdaq

News & Analysis

First Insights into China’s New Corporate Landscape

05 January 2024 by Ray SHI, Claire XU

Barely a week ago on December 29, 2023, China’s legislative body passed and President Xi Jinping signed into law the newly revised Company Law, effective from July 1, 2024 (the “New Law”).

News & Analysis

Anatomy of Licensing Deals from China Regulatory Perspective

04 January 2024 by Aaron GU, Pengfei YOU, Duzhiyun ZHENG, Yuzhen ZHANG, Fengqi YU

Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.

News & Analysis

ESG Banking Products in China — (I) Green Deposits

03 January 2024 by Ting ZHENG, Raymond YAN, Eryin YING, Lin ZHU

ESG is in high alignment with China’s “dual carbon” goals and has become an important indicator for measuring the sustainable and high-quality development of enterprises in China

News & Analysis

Han Kun Releases Its 2022 VC/PE Data Analysis Report

18 September 2023 by Han Kun Law Offices - China

Onshore Transactions Continued their Upward Trend, the Biomedical Sector Remained the Most Popular Investment Destination

News & Analysis

Han Kun Releases 2021 Fund Practice Data Analysis Report: PE fund market rebounded. Smart hardware and biomedicine retained the crown

02 December 2022 by Han Kun Law Offices - China

In 2021, markets appeared to reach a new equilibrium following the widespread rampage wrought by Covid-19 the year before, as many economies gradually adjusted to the “new normal” and business activities saw a sharp rebound.

News & Analysis

Han Kun Releases 2021 Fund Practice Data Analysis Report: PE fund market rebounded. Smart hardware and biomedicine retained the crown

02 December 2022 by Han Kun Law Offices - China

In 2021, markets appeared to reach a new equilibrium following the widespread rampage wrought by Covid-19 the year before, as many economies gradually adjusted to the “new normal” and business activities saw a sharp rebound.

News & Analysis

Han Kun releases its 2021 VC/PE Deal Data Analysis Report

19 July 2022 by Han Kun Law Offices - China

Biomedicine remained the No.1 investment destination, FIE structures increasingly favored by dealmakers in onshore transactions Han Kun Law Offices has released the Han Kun 2021 VC/PE Deal Data Analysis Report (English edition, the “Report”).

News & Analysis

Han Kun releases its 2021 VC/PE Deal Data Analysis Report

19 July 2022 by Han Kun Law Offices - China

Biomedicine remained the No.1 investment destination, FIE structures increasingly favored by dealmakers in onshore transactions Han Kun Law Offices has released the Han Kun 2021 VC/PE Deal Data Analysis Report (English edition, the “Report”).

News & Analysis

汉坤争议解决简报︱Dispute Resolution Trends in China

17 May 2022 by Han Kun Law Offices - China

On April 22, 2022, Chengdu International Commercial Court was officially established. It is the third international commercial court in China after the establishment of the Suzhou International Commercial Court and the Beijing International Commercial Court, and exercises centralized jurisdiction over the first instance proceeding of all foreign-related civil and commercial cases that should have been heard by intermediate people’s courts within Sichuan Province.